Research to Practice
Research to Practice is a private, accredited medical education company founded in 1985 by Dr. Neil Love that produces CME and NCPD content for U.S. oncology and hematology clinicians. Funded entirely by pharmaceutical educational grants, it distributes 300+ hours of accredited programming via a digital platform, mobile apps, podcasts, and live events.
- Company typePrivate
- Founded1985
- HeadquartersMiami, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Research to Practice does
Research to Practice (RTP) is a private, accredited medical education company founded in 1985 by medical oncologist Neil Love, MD, and headquartered in Key Biscayne (Miami), Florida. The company produces oncology and hematology continuing education content — including CME for physicians and NCPD for nurses — distributed to U.S. cancer clinicians across medical oncology, hematology, surgical oncology, radiation oncology, and advanced practice nursing. RTP's content library spans 300+ hours of accredited programming across 225+ activities and 400+ programs covering breast, lung, gastrointestinal, genitourinary, gynecologic, hematologic, and dermatologic cancers, delivered via a digital platform (researchtopractice.com), native iOS/Android apps, nine podcast series, live webinars, microlearning modules, and an annual national summit.
The underlying technology is a content-centric digital education platform with single sign-on, robust search, and direct integration into CME/NCPD certification systems (ACCME, ANCC, ABIM MOC, ABS Continuous Certification); the platform was fully redesigned and relaunched in June 2026. RTP operates a multi-format content engine (faculty presentations, symposium proceedings, one-on-one investigator interviews, case-based discussions, nursing symposia, Patterns of Care studies) produced with 260+ faculty members and clinical investigators. Following its November 2025 acquisition by Stamford-based healthcare communications firm The Lockwood Group, RTP continues to operate as a subsidiary under Dr. Love's leadership.
RTP's revenue model is entirely grant-funded: educational grants from 60+ pharmaceutical and biotech commercial supporters (including Gilead Sciences, Genentech/Roche, Pfizer, Merck, and Bristol Myers Squibb) underwrite content production, allowing all CME/NCPD activities to be offered complimentary to end users. The company generates no direct revenue from clinicians and prices content at zero to physicians and nurses. Go-to-market is event-driven and digital-first, leveraging flagship live events (Annual National General Medical Oncology Summit), webinars, podcasts, and institutional partnerships (Florida Cancer Specialists & Research Institute, American Oncology Network) to drive clinician engagement and, by extension, sustained pharma grant funding.
Research to Practice firmographics
Firmographics- Name
- Research to Practice
- Legal name
- Research To Practice
- Website
- https://researchtopractice.com
- Company type
- Private
- Founded year
- 1985
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Research to Practice is a private, accredited medical education company founded in 1985 by Dr. Neil Love that produces CME and NCPD content for U.S. oncology and hematology clinicians. Funded entirely by pharmaceutical educational grants, it distributes 300+ hours of accredited programming via a digital platform, mobile apps, podcasts, and live events.
- Ownership category
- akta.pro rank
Research to Practice industry classification
Industry- Product category
- Continuing Medical Education (Oncology)
- NAICS
- Educational Services (611), Educational Support Services (61171)
- SIC
- Services-Educational Services (8200)
- akta.pro primary industry
- Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)
- akta.pro secondary industries
- Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)
Keywords
Where Research to Practice is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Research to Practice business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Educational Grants from Pharmaceutical Companies: RTP operates as a medical education company funded by educational grants from pharmaceutical and biotech companies. The company receives funds from commercial supporters including companies like Gilead Sciences Inc, Genentech/Roche, Pfizer Inc, Merck, Bristol Myers Squibb, and over 60 other companies to develop CME/NCPD activities. This is the primary revenue model enabling complimentary access to healthcare professionals.
- Complimentary CME/NCPD Activities: RTP offers a variety of complimentary CME/NCPD activities and series for physicians, nurses, and other healthcare professionals in practice. All educational content is provided free to end users, funded entirely by pharmaceutical company educational grants.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Annual | Complimentary access to all CME/NCPD accredited activities |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
Research to Practice product offering
Product offeringCore offering
Research To Practice produces and distributes accredited continuing medical education (CME) and nursing continuing professional development (NCPD) content for oncology and hematology clinicians in the United States. Its core deliverable is a digital education platform offering more than 300 hours of accredited programming across 225+ activities featuring 260+ clinical investigators as faculty, delivered via website, mobile apps, podcasts, live webinars, and in-person summits. RTP is funded by educational grants from pharmaceutical and biotech companies, allowing all CME/NCPD activities to be offered free of charge to healthcare professionals.
Product overview
Research To Practice operates a unified digital education platform offering accredited CME and NCPD content for oncology professionals. The portfolio includes the core digital platform (researchtopractice.com) with mobile apps for iOS and Android, plus an extensive library of podcasts (Oncology Today with Dr Neil Love, Breast Cancer Update, Hematologic Oncology Update, Gastrointestinal Cancer Update, Lung Cancer Update, Prostate Cancer Update, Gynecologic Cancer Update, Dermatologic Oncology Update) and video content. Content is organized into structured collections including What Clinicians Want to Know, Year in Review, Microlearning Activity, Oncology Today with Dr Neil Love, Nursing Symposium, and Expert Second Opinion, spanning tumor types (breast, GI, GU, hematologic, lung, gynecologic, dermatologic, multitumor) and formats (faculty presentations, webinars, symposium proceedings, nursing programs, microlearning, interviews). The company was acquired by The Lockwood Group in November 2025.
Differentiator
Problem solved
Functional benefit
Products and services
- Research To Practice Digital Platform Primary digital education platform at researchtopractice.com delivering accredited CME and NCPD content to oncology clinicians, with over 300 hours of programming across 225+ activities spanning breast, lung, GI, GU, gynecologic, hematologic, dermatologic, and multitumor oncology; includes single sign-on, robust search, and direct integration with ABIM MOC, ABS MOC, ACCME, and ANCC certification systems for seamless credit claiming.
- RTP Mobile App (iOS and Android)
Quantifiable outcome
- Programs used by the vast majority of cancer clinicians in the United States
- +2 more outcomes
Companies that use Research to Practice
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles2 records
Research to Practice technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Research to Practice partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and major.
- Florida Cancer Specialists & Research Institute (FCS)coreFlorida Cancer Specialists & Research Institute partnered with Research to Practice for the Fifth Annual National General Medical Oncology Summit in Orlando, Florida. This exclusive event convenes leading oncology experts to share cutting-edge data and emerging treatment strategies for personalized cancer care in community settings. FCS President Dr. Lucio N. Gordan emphasized the program delivers actionable insights supporting clinical and operational decision-making for medical oncologists and frontline cancer care professionals.
- The Lockwood GroupcoreThe Lockwood Group, a healthcare PR firm based in Stamford, Connecticut, acquired Research To Practice in November 2025. The deal expands The Lockwood Group's global healthcare services capabilities and enhances evidence-based resources and support for oncology clinicians worldwide. RTP, founded by Dr. Neil Love in Miami, provides oncology-focused medical education content and formats. The acquisition represents RTP's continued investment in accessible oncology education across digital, live, and on-demand channels under the parent company's umbrella.
- American Oncology Network (AON)majorResearch to Practice partnered with the American Oncology Network for the AON 2025 event, delivering a multitumor symposium titled 'Integrating New Advances into the Care of Patients with Cancer' covering lung cancer, chronic lymphocytic leukemia, and other topics. This partnership brings RTP's educational content to AON's network of community oncology practices.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Research to Practice competitors and assessment
Company assessmentBroad incumbents
- Medscape Education: Operated by WebMD, Medscape Education is the largest free online CME/CE destination for clinicians globally. It overlaps directly with RTP in oncology CME offerings and competes for the same pharma educational grant dollars, though across many more therapeutic areas.
- Haymarket Medical Education: Haymarket's medical education division delivers accredited CME/CE across multiple specialties including oncology through its mycme.com platform. It is comparable to RTP as a pharma-grant-funded CME publisher with multi-specialty reach.
- Pri-Med: Owned by MDEdge, Pri-Med is a large CME provider serving primary care and specialty clinicians through live conferences and online education. It overlaps with RTP at the broader CME/grant-funded intersection and competes for shared sponsor budgets.
Direct peers
- Clinical Care Options (CCO): CCO is a privately-held medical education company offering accredited CME/CE across oncology, HIV, and other specialties. It competes with RTP directly for pharma educational grants in oncology and operates a similar digital, live-event, and expert-interview content model.
- OncLive (MJH Life Sciences): MJH Life Sciences' OncLive platform provides oncology-focused news, interviews, and CME activities targeted at the same practicing oncologist audience as RTP. Both produce interview-driven, faculty-led content under pharma-supported models.
- Vindico Medical Education: Vindico is an accredited provider of CME/CE content using a pharma-supported, expert-faculty model for specialist audiences including oncology. It directly competes with RTP for sponsor grants and clinician engagement in specialty CME.
- PlatformQ Health: PlatformQ Health produces digital CME/CE activities (webinars, online symposia, video interviews) for clinicians, including oncology content funded by pharma grants. It is directly comparable to RTP in digital-first CME delivery.
- Physicians' Education Resource (PER): PER designs oncology-specific CME-certified activities, including live meetings, symposia, and online programs funded by pharma grants. It overlaps with RTP in audience, funding model, and content format (live symposia + enduring CME).
Others
- MedPage Today: MedPage Today provides oncology news and accredited CME activities to practicing clinicians and competes with RTP for clinician attention and pharma-sponsored education budgets across overlapping specialist audiences.
- National Comprehensive Cancer Network (NCCN): NCCN is a not-for-profit alliance of leading cancer centers producing clinical practice guidelines and accredited oncology education. While not for-profit and not grant-funded in the same way, it competes with RTP for clinician mindshare in oncology decision-making content.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Research to Practice social profiles
Digital presenceResearch to Practice compliance and trust
Trust signalCompliance4 records
Research to Practice financial estimates
Financial estimateRevenue estimate
Valuation estimate
Research to Practice leadership team
Management profileNumber of profiles
Profiles2 records
Research to Practice funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Research to Practice M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Research to Practice
What does Research to Practice do?
Research To Practice produces and distributes accredited continuing medical education (CME) and nursing continuing professional development (NCPD) content for oncology and hematology clinicians in the United States. Its core deliverable is a digital education platform offering more than 300 hours of accredited programming across 225+ activities featuring 260+ clinical investigators as faculty, delivered via website, mobile apps, podcasts, live webinars, and in-person summits. RTP is funded by educational grants from pharmaceutical and biotech companies, allowing all CME/NCPD activities to be offered free of charge to healthcare professionals.
Is Research to Practice a public or private company?
Research to Practice is a private company. It is classified as corporate owned and is currently operating.
When was Research to Practice founded?
Research to Practice was founded in 1985. It employs 51 to 100 people.
Where is Research to Practice based?
Research to Practice is headquartered in Miami, United States, in the North America region.
How does Research to Practice make money?
Two revenue lines are on record. Educational Grants from Pharmaceutical Companies are the primary driver. The others are complimentary CME/NCPD Activities.
Who are Research to Practice's main competitors?
Broad incumbents on record are Medscape Education, Haymarket Medical Education and Pri-Med. Direct peers are Clinical Care Options (CCO), OncLive (MJH Life Sciences), Vindico Medical Education, PlatformQ Health and Physicians' Education Resource (PER). Others are MedPage Today and National Comprehensive Cancer Network (NCCN).
Does Research to Practice have an API?
No public API is recorded for Research to Practice.
What industry is Research to Practice in?
Research to Practice's product category is Continuing Medical Education (Oncology). Its primary akta.pro industry code is EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE), with a secondary code of EDAAALAC, Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy). Its NAICS code is 611 and its SIC code is 8200.